Mary A. Gutierrez

403 total citations
12 papers, 279 citations indexed

About

Mary A. Gutierrez is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Mary A. Gutierrez has authored 12 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Pharmacology. Recurrent topics in Mary A. Gutierrez's work include Sexual function and dysfunction studies (5 papers), Hormonal and reproductive studies (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Mary A. Gutierrez is often cited by papers focused on Sexual function and dysfunction studies (5 papers), Hormonal and reproductive studies (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Mary A. Gutierrez collaborates with scholars based in United States, United Kingdom and Hong Kong. Mary A. Gutierrez's co-authors include Glen L. Stimmel, Vivian Lee, Jeffery A. Goad, Sian M. Carr‐Lopez, Joseph M. Pierre, Donna Ames, Yu Ke, Yun Wang, Todd Schneberk and Michael B. Nichol and has published in prestigious journals such as Clinical Therapeutics, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Psychiatric Clinics of North America.

In The Last Decade

Mary A. Gutierrez

11 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary A. Gutierrez United States 8 135 48 44 40 26 12 279
N. Bergemann Germany 9 150 1.1× 44 0.9× 47 1.1× 20 0.5× 21 0.8× 23 329
Tawny L Bettinger United States 8 269 2.0× 69 1.4× 42 1.0× 56 1.4× 21 0.8× 13 369
Cheng‐Cheng Hsiao Taiwan 12 162 1.2× 82 1.7× 86 2.0× 67 1.7× 28 1.1× 20 412
Christine Gispen‐de Wied Netherlands 10 108 0.8× 42 0.9× 31 0.7× 68 1.7× 50 1.9× 17 396
Fude Yang China 12 149 1.1× 55 1.1× 40 0.9× 37 0.9× 57 2.2× 28 391
Sheila Assunção-Talbott United States 8 308 2.3× 57 1.2× 32 0.7× 72 1.8× 22 0.8× 9 367
Niko Seppälä Finland 12 251 1.9× 53 1.1× 30 0.7× 29 0.7× 55 2.1× 20 398
João Vian Portugal 6 77 0.6× 41 0.9× 26 0.6× 21 0.5× 24 0.9× 8 274
Hugh McGuire United Kingdom 5 164 1.2× 115 2.4× 28 0.6× 49 1.2× 32 1.2× 13 334
Zorana Pavlović Serbia 10 70 0.5× 45 0.9× 38 0.9× 62 1.6× 42 1.6× 20 371

Countries citing papers authored by Mary A. Gutierrez

Since Specialization
Citations

This map shows the geographic impact of Mary A. Gutierrez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary A. Gutierrez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary A. Gutierrez more than expected).

Fields of papers citing papers by Mary A. Gutierrez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary A. Gutierrez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary A. Gutierrez. The network helps show where Mary A. Gutierrez may publish in the future.

Co-authorship network of co-authors of Mary A. Gutierrez

This figure shows the co-authorship network connecting the top 25 collaborators of Mary A. Gutierrez. A scholar is included among the top collaborators of Mary A. Gutierrez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary A. Gutierrez. Mary A. Gutierrez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wang, Yun, Todd Schneberk, Yu Ke, et al.. (2023). What quantifies good primary care in the United States? A review of algorithms and metrics using real-world data. BMC Primary Care. 24(1). 130–130. 1 indexed citations
2.
Gutierrez, Mary A., et al.. (2018). Use of virtual games for interactive learning in a pharmacy curriculum. Currents in Pharmacy Teaching and Learning. 11(1). 51–57. 31 indexed citations
3.
Ames, Donna, et al.. (2016). Detecting and Managing Adverse Effects of Antipsychotic Medications. Psychiatric Clinics of North America. 39(2). 275–311. 26 indexed citations
4.
Gutierrez, Mary A., et al.. (2008). Chapter 8 Sexual Dysfunction in Women with Epilepsy. International review of neurobiology. 83. 157–167. 6 indexed citations
5.
Stimmel, Glen L. & Mary A. Gutierrez. (2006). Sexual Dysfunction and Psychotropic Medications. CNS Spectrums. 11(S9). 24–30. 37 indexed citations
6.
Stimmel, Glen L. & Mary A. Gutierrez. (2006). Counseling Patients About Sexual Issues. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(11). 1608–1615. 5 indexed citations
7.
Stimmel, Glen L. & Mary A. Gutierrez. (2006). Pharmacologic Treatment Strategies for Sexual Dysfunction in Patients with Epilepsy and Depression. CNS Spectrums. 11(S9). 31–37. 11 indexed citations
8.
Gutierrez, Mary A., et al.. (2003). Venlafaxine: A 2003 update. Clinical Therapeutics. 25(8). 2138–2154. 72 indexed citations
9.
Stimmel, Glen L., Mary A. Gutierrez, & Vivian Lee. (2002). Ziprasidone: An atypical antipsychotic drug for the treatment of schizophrenia. Clinical Therapeutics. 24(1). 21–37. 63 indexed citations
10.
Gutierrez, Mary A., et al.. (2001). Paradoxical Reactions to Benzodiazepines. AJN American Journal of Nursing. 101(7). 34–39. 14 indexed citations
11.
Gutierrez, Mary A. & Glen L. Stimmel. (1999). Management of and Counseling for Psychotropic Drug‐Induced Sexual Dysfunction. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(7). 823–831. 12 indexed citations
12.
Gutierrez, Mary A., et al.. (1996). Development and implementation of drug use evaluation (DUE) criteria for risperidone in an outpatient psychiatric setting.. PubMed. 32(4). 705–19. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026